Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4283]

Contrast-enhanced mammography vs MRI: Neoadjuvant therapy response in breast cancer

Contrast-enhanced mammography vs MRI: Neoadjuvant therapy response in breast cancer

Breast cancer mainly spreads at night

Breast cancer mainly spreads at night

NICE recommends abemaciclib in combination with endocrine therapy for adjuvant treatment of HR+/HER2- early breast cancer

NICE recommends abemaciclib in combination with endocrine therapy for adjuvant treatment of HR+/HER2- early breast...

Tumour ‘signatures’ could provide key to more accurate treatment for deadliest cancers

Tumour ‘signatures’ could provide key to more accurate treatment for deadliest cancers

Novel DNA aptamer for CYP24A1 inhibition ID’d, possible target for anticancer therapy

Novel DNA aptamer for CYP24A1 inhibition ID’d, possible target for anticancer therapy

ASCO 2022: Biomarker guidance allows patients 55 or older with low-grade luminal A-type breast cancer to avoid radiation therapy

ASCO 2022: Biomarker guidance allows patients 55 or older with low-grade luminal A-type breast cancer to avoid...

ASCO 2022: Novel antibody-drug conjugate doubles progression-free survival in metastatic breast cancer with low HER2 expression levels

ASCO 2022: Novel antibody-drug conjugate doubles progression-free survival in metastatic breast cancer with low...

ASCO 2022: ASCO & WHO to collaborate on quality indicators for cancer facilities worldwide

ASCO 2022: ASCO & WHO to collaborate on quality indicators for cancer facilities worldwide

ASCO 2022: Novel agent increases PFS for patients with the most common type of advanced breast cancer

ASCO 2022: Novel agent increases PFS for patients with the most common type of advanced breast cancer

Ultrasound-guided microbubbles boost immunotherapy efficacy

Ultrasound-guided microbubbles boost immunotherapy efficacy

More from ecancer